Vivos Therapeutics, Inc. 8-KCurrent Reports (8-K / ad hoc)

Business

Item 1.01. Entry into a Material Definitive Agreement. The information set forth under Item 5.02 of this Current Report on Form 8-K regarding the Separation, Resignation and Executive Transition Agreement, dated as of July 31, 2026 (the “ Separation Agreement ”), between Vivos Therapeutics, Inc. (the “ Company ”) and Bradford Amman, and the Master Services Agreement, dated as of July 31, 2026 (the “ MSA ”), between the Company and The CFO Portal, LLC (“ CFO Portal ”), is incorporated by reference into this Item 1.01.